Ibandronate Sodium Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) Troop Support has awarded Golden State Medical Supply, Inc. a contract (SPE2D2-26-D-0015) for Ibandronate Sodium Tablets. This award, valued at an estimated $2,364,029.99 over five years, provides essential pharmaceutical supplies.
Scope of Work
This contract covers the supply of Ibandronate Sodium Tablets 150MG (3 Count), identified by National Drug Code (NDC) 60429-0643-73. The quantities specified are estimates, and the contract includes a Base Year and four Option Years.
Contract & Timeline
- Contract Number: SPE2D2-26-D-0015
- Awardee: Golden State Medical Supply, Inc.
- Award Date: May 7, 2026
- Estimated Value: $2,364,029.99
- Period of Performance: Estimated 5 years (Base Year + 4 Option Years)
- Contract Type: Appears to be Fixed-Price
- Set-Aside: For DLA and VA Pharmaceutical Prime Vendors
Evaluation
This award resulted from solicitation SPE2D2-25-R-0019. Golden State Medical Supply, Inc.'s offer, dated October 10, 2025, was accepted after Final Proposal Revisions were opened on April 13, 2026.
Additional Notes
The acquisition falls under NAICS Code 325412 (Pharmaceutical and Medicine Manufacturing) with a size standard of 1300 employees. The place of manufacture is Apotex Corporation in Canada, with packing facilities at Golden State Medical Supply, Inc. in Camarillo, CA. The contract incorporates by reference various FAR and DFARS clauses.